Prognostic Value of Microscopic Tumor Necrosis in Adrenal Cortical Carcinoma
Adrenal cortical carcinoma (ACC) is an uncommon neoplasm with variable prognosis. Several histologic criteria have been identified as predictors of malignancy in adrenal cortical tumors. The Weiss score is the system most widely employed for diagnostic purposes, but also possesses prognostic value....
Saved in:
Published in: | Endocrine pathology Vol. 34; no. 2; pp. 224 - 233 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
New York
Springer US
01-06-2023
Springer Nature B.V |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Adrenal cortical carcinoma (ACC) is an uncommon neoplasm with variable prognosis. Several histologic criteria have been identified as predictors of malignancy in adrenal cortical tumors. The Weiss score is the system most widely employed for diagnostic purposes, but also possesses prognostic value. We aim to determine the relative impact of each Weiss parameter on ACC patient survival. A multicenter retrospective analysis was conducted on a series of 79 conventional ACCs surgically treated at the Florence and Utrecht centers of the European Network for the Study of Adrenal Tumors (ENSAT). Weiss classification was recapitulated using principal component analysis (PCA). The Kaplan–Meier and Cox multivariate regression analyses were applied in order to estimate the prognostic power of Weiss versus other clinical parameters. PCA reduced the nine Weiss parameters to the best fitting 4-component model, each parameter clustering with a single component. Necrosis and venous invasion clustered together with the highest scores, thus establishing the most relevant component (Component 1) to explain Weiss distribution variability. Only Component 1 significantly predicted overall survival (OS, log-rank = 0.008) and disease-free survival (DFS, log-rank < 0.001). When considering the prognostic power of Weiss parameters, necrosis alone could independently assess OS (log-rank = 0.004) and DFS (log-rank < 0.001) at both the Kaplan–Meier and multivariate Cox regression analyses [hazard ratio (HR) = 7.8, 95% confidence interval [CI] = 1.0–63.5,
p
= 0.05, and HR = 12.2, 95% CI = 1.6–95.0,
p
= 0.017, respectively]. The presence of necrosis significantly shortened time to survival (TtS) and time to recurrence (TtR), 57.5 [31.5–103.5] vs 34 [12–78] months (
p
= 0.05) and 57.5 [31.5–103.5] vs 7 [1.0–31.5] months (
p
< 0.001), respectively. Our study suggests that, of the Weiss parameters, necrosis is the most powerful adverse factor and the best predictor of OS and DFS in ACC patients. |
---|---|
AbstractList | Adrenal cortical carcinoma (ACC) is an uncommon neoplasm with variable prognosis. Several histologic criteria have been identified as predictors of malignancy in adrenal cortical tumors. The Weiss score is the system most widely employed for diagnostic purposes, but also possesses prognostic value. We aim to determine the relative impact of each Weiss parameter on ACC patient survival. A multicenter retrospective analysis was conducted on a series of 79 conventional ACCs surgically treated at the Florence and Utrecht centers of the European Network for the Study of Adrenal Tumors (ENSAT). Weiss classification was recapitulated using principal component analysis (PCA). The Kaplan–Meier and Cox multivariate regression analyses were applied in order to estimate the prognostic power of Weiss versus other clinical parameters. PCA reduced the nine Weiss parameters to the best fitting 4-component model, each parameter clustering with a single component. Necrosis and venous invasion clustered together with the highest scores, thus establishing the most relevant component (Component 1) to explain Weiss distribution variability. Only Component 1 significantly predicted overall survival (OS, log-rank = 0.008) and disease-free survival (DFS, log-rank < 0.001). When considering the prognostic power of Weiss parameters, necrosis alone could independently assess OS (log-rank = 0.004) and DFS (log-rank < 0.001) at both the Kaplan–Meier and multivariate Cox regression analyses [hazard ratio (HR) = 7.8, 95% confidence interval [CI] = 1.0–63.5,
p
= 0.05, and HR = 12.2, 95% CI = 1.6–95.0,
p
= 0.017, respectively]. The presence of necrosis significantly shortened time to survival (TtS) and time to recurrence (TtR), 57.5 [31.5–103.5] vs 34 [12–78] months (
p
= 0.05) and 57.5 [31.5–103.5] vs 7 [1.0–31.5] months (
p
< 0.001), respectively. Our study suggests that, of the Weiss parameters, necrosis is the most powerful adverse factor and the best predictor of OS and DFS in ACC patients. Adrenal cortical carcinoma (ACC) is an uncommon neoplasm with variable prognosis. Several histologic criteria have been identified as predictors of malignancy in adrenal cortical tumors. The Weiss score is the system most widely employed for diagnostic purposes, but also possesses prognostic value. We aim to determine the relative impact of each Weiss parameter on ACC patient survival. A multicenter retrospective analysis was conducted on a series of 79 conventional ACCs surgically treated at the Florence and Utrecht centers of the European Network for the Study of Adrenal Tumors (ENSAT). Weiss classification was recapitulated using principal component analysis (PCA). The Kaplan–Meier and Cox multivariate regression analyses were applied in order to estimate the prognostic power of Weiss versus other clinical parameters. PCA reduced the nine Weiss parameters to the best fitting 4-component model, each parameter clustering with a single component. Necrosis and venous invasion clustered together with the highest scores, thus establishing the most relevant component (Component 1) to explain Weiss distribution variability. Only Component 1 significantly predicted overall survival (OS, log-rank = 0.008) and disease-free survival (DFS, log-rank < 0.001). When considering the prognostic power of Weiss parameters, necrosis alone could independently assess OS (log-rank = 0.004) and DFS (log-rank < 0.001) at both the Kaplan–Meier and multivariate Cox regression analyses [hazard ratio (HR) = 7.8, 95% confidence interval [CI] = 1.0–63.5, p = 0.05, and HR = 12.2, 95% CI = 1.6–95.0, p = 0.017, respectively]. The presence of necrosis significantly shortened time to survival (TtS) and time to recurrence (TtR), 57.5 [31.5–103.5] vs 34 [12–78] months (p = 0.05) and 57.5 [31.5–103.5] vs 7 [1.0–31.5] months (p < 0.001), respectively. Our study suggests that, of the Weiss parameters, necrosis is the most powerful adverse factor and the best predictor of OS and DFS in ACC patients. |
Author | Roebaar, Rogina Mannelli, Massimo Cantini, Giulia Santi, Raffaella Ercolino, Tonino Canu, Letizia Nesi, Gabriella van Leeuwaarde, Rachel S. Luconi, Michaela Fei, Laura de Krijger, Ronald R. Propato, Arianna Pia |
Author_xml | – sequence: 1 givenname: Michaela surname: Luconi fullname: Luconi, Michaela email: michaela.luconi@unifi.it organization: Endocrinology Unit, Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence, Centro di Ricerca E Innovazione Sulle Patologie Surrenaliche, AOU Careggi, ENS@T Center of Excellence – sequence: 2 givenname: Giulia surname: Cantini fullname: Cantini, Giulia organization: Endocrinology Unit, Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence, Centro di Ricerca E Innovazione Sulle Patologie Surrenaliche, AOU Careggi, ENS@T Center of Excellence – sequence: 3 givenname: Rachel S. surname: van Leeuwaarde fullname: van Leeuwaarde, Rachel S. organization: Department of Endocrine Oncology, University Medical Center Utrecht – sequence: 4 givenname: Rogina surname: Roebaar fullname: Roebaar, Rogina organization: Department of Endocrine Oncology, University Medical Center Utrecht – sequence: 5 givenname: Laura surname: Fei fullname: Fei, Laura organization: Endocrinology Unit, Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence – sequence: 6 givenname: Arianna Pia surname: Propato fullname: Propato, Arianna Pia organization: Endocrinology Unit, Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence – sequence: 7 givenname: Raffaella surname: Santi fullname: Santi, Raffaella organization: Pathology Section, Department of Health Sciences, University of Florence – sequence: 8 givenname: Tonino surname: Ercolino fullname: Ercolino, Tonino organization: Endocrinology Unit, Careggi University Hospital (AOUC) – sequence: 9 givenname: Massimo surname: Mannelli fullname: Mannelli, Massimo organization: Endocrinology Unit, Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence, Centro di Ricerca E Innovazione Sulle Patologie Surrenaliche, AOU Careggi, ENS@T Center of Excellence – sequence: 10 givenname: Letizia surname: Canu fullname: Canu, Letizia organization: Endocrinology Unit, Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Florence, Centro di Ricerca E Innovazione Sulle Patologie Surrenaliche, AOU Careggi, ENS@T Center of Excellence – sequence: 11 givenname: Ronald R. surname: de Krijger fullname: de Krijger, Ronald R. organization: Princess Maxima Center for Pediatric Oncology, Department of Pathology, University Medical Center Utrecht – sequence: 12 givenname: Gabriella surname: Nesi fullname: Nesi, Gabriella email: gabriella.nesi@unifi.i organization: Centro di Ricerca E Innovazione Sulle Patologie Surrenaliche, AOU Careggi, ENS@T Center of Excellence, Pathology Section, Department of Health Sciences, University of Florence |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36952130$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UU1v2zAMFYYUS9PtD-xQGOhlF6-UZMnyqQiCdi2Qfhy6XQXFplMFtpRJ8YD9-8pN17U79CSS7_GR4puRifMOCflC4RsFKE8jZcBYDoznUJUScvmBHFIhqhxSPkkxFDLnCZqSWYwbAMoB2Ecy5bISLCWHZHkX_Nr5uLN19tN0A2a-za5tHXys_TYV74feh-wGx4qNmXXZvAnoTJctfEhdY2BCbZ3vzSdy0Jou4ufn94j8uDi_X1zmy9vvV4v5Mq-LUuxyrpDRsjVIayiEqZBDu1KiqUpYNZIabBSv2gZRIaSdS1msSg5cCSVlWYHiR-Rsr7sdVj02NbpdMJ3eBtub8Ed7Y_VbxNkHvfa_NQUmCyZ5Uvj6rBD8rwHjTvc21th1xqEfomZpDgigdKSe_Efd-CGkAySWYkKoinKRWGzPGu8UA7Yv21DQo1t675ZObuknt7RMTcev__HS8teeROB7QkyQW2P4N_sd2UeGKaD_ |
CitedBy_id | crossref_primary_10_1007_s12022_023_09776_y crossref_primary_10_3390_ijms242316573 |
Cites_doi | 10.1016/j.humpath.2020.10.001 10.1210/clinem/dgab866 10.3390/cancers11121931 10.1007/s40618-017-0775-y 10.3390/cancers12113176 10.1245/s10434-020-09562-8 10.1001/jamaoncol.2019.1558 10.1016/j.canep.2014.02.004 10.1016/j.humpath.2009.03.010 10.3390/cancers12010247.5 10.1093/annonc/mdv329 10.1016/j.humpath.2014.11.015 10.3389/fcell.2020.00332 10.1097/PAS.0b013e31828d387b 10.1210/jc.2014-3182 10.1007/s12022-022-09710-8 10.1530/ERC-17-0440 10.1002/cncr.24030 10.1016/j.humpath.2016.09.035 10.1007/0-387-22440-8_13 10.1210/endocr/bqac102 |
ContentType | Journal Article |
Copyright | The Author(s) 2023 2023. The Author(s). The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2023 – notice: 2023. The Author(s). – notice: The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C NPM AAYXX CITATION 3V. 7QP 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PQEST PQQKQ PQUKI 7X8 5PM |
DOI | 10.1007/s12022-023-09760-6 |
DatabaseName | Springer Open Access PubMed CrossRef ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Pharma Collection ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef ProQuest One Academic Eastern Edition PubMed |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1559-0097 |
EndPage | 233 |
ExternalDocumentID | 10_1007_s12022_023_09760_6 36952130 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Università degli Studi di Firenze – fundername: Associazione Italiana Ricerca sul Cancro (AIRC) grantid: IG2015-17691 – fundername: ; – fundername: ; grantid: IG2015-17691 |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 1N0 2.D 203 28- 29G 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 3V. 4.4 406 408 40D 40E 53G 5GY 5VS 6NX 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AABYN AAFGU AAHNG AAIAL AAJKR AAKSU AANXM AANZL AAPBV AARHV AARTL AATNV AATVU AAUYE AAWCG AAYFA AAYIU AAYQN AAYTO ABDZT ABECU ABFGW ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKAS ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABUWG ABWNU ABXPI ACBMV ACBRV ACBYP ACCUX ACGFS ACHSB ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACSNA ACTTH ACUDM ACVWB ACWMK ADBBV ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADMDM ADOXG ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEEQQ AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFAFS AFEXP AFKRA AFLOW AFNRJ AFQWF AFWTZ AFZKB AGAYW AGDGC AGGBP AGGDS AGJBK AGKHE AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJZVZ AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BVXVI C6C CAG CCPQU COF CS3 CSCUP DDRTE DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMOBN ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GRRUI HF~ HG6 HMCUK HMJXF HRMNR HVGLF HZ~ IJ- IKXTQ IMOTQ IWAJR IXD I~X I~Z J-C J0Z JBSCW JZLTJ KOV LLZTM M1P M4Y MA- N2Q NB0 NDZJH NF0 NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TT1 TUC U2A U9L UG4 UKHRP UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W48 WK8 YLTOR Z82 Z8V ZMTXR ZOVNA ~A9 ~EX ~KM AACDK AAEOY AAJBT AASML AAYZH ABAKF ACAOD ACDTI ACZOJ AEFQL AEMSY AFBBN AGQEE AGRTI AIGIU AJOOF ALIPV H13 NPM SJYHP AAYXX CITATION 7QP 7XB 8FK K9. PQEST PQUKI 7X8 5PM |
ID | FETCH-LOGICAL-c475t-38e217fae1c045a9e30fb85d970bd61aed839fdee8e0001764b73038586679083 |
IEDL.DBID | AEJHL |
ISSN | 1046-3976 |
IngestDate | Tue Sep 17 21:30:02 EDT 2024 Fri Oct 25 21:23:00 EDT 2024 Wed Nov 06 07:14:33 EST 2024 Fri Nov 22 00:33:20 EST 2024 Wed Oct 16 00:39:18 EDT 2024 Sat Dec 16 12:06:46 EST 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | ACC Survival analysis Weiss score Principal component analysis |
Language | English |
License | 2023. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c475t-38e217fae1c045a9e30fb85d970bd61aed839fdee8e0001764b73038586679083 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://link.springer.com/10.1007/s12022-023-09760-6 |
PMID | 36952130 |
PQID | 2825589135 |
PQPubID | 326340 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_10264263 proquest_miscellaneous_2790050113 proquest_journals_2825589135 crossref_primary_10_1007_s12022_023_09760_6 pubmed_primary_36952130 springer_journals_10_1007_s12022_023_09760_6 |
PublicationCentury | 2000 |
PublicationDate | 2023-06-01 |
PublicationDateYYYYMMDD | 2023-06-01 |
PublicationDate_xml | – month: 06 year: 2023 text: 2023-06-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York – name: United States – name: Cambridge |
PublicationTitle | Endocrine pathology |
PublicationTitleAbbrev | Endocr Pathol |
PublicationTitleAlternate | Endocr Pathol |
PublicationYear | 2023 |
Publisher | Springer US Springer Nature B.V |
Publisher_xml | – name: Springer US – name: Springer Nature B.V |
References | Lacombe, Soares, Mariani, Nishi, Bezerra-Neto, Charchar, Brondani, Tanno, Srougi, Chambo, Costa de Freitas, Mendonca, Hoff, Almeida, Weigand, Kroiss, Zerbini, Fragoso (CR19) 2020; 12 Cantini, Canu, Armignacco, Salvianti, De Filpo, Ercolino, Nesi, Maggi, Mannelli, Pinzani, Luconi (CR7) 2020; 12 (CR13) 2009; 115 Baechle, Marincola Smith, Solórzano, Tran, Postlewait, Maithel, Prescott, Pawlik, Wang, Glenn, Hatzaras, Shenoy, Phay, Shirley, Fields, Jin, Abbott, Ronnekleiv-Kelly, Sicklick, Yopp, Mansour, Duh, Seiser, Votanopoulos, Levine, Poultsides, Kiernan (CR15) 2021; 28 Duregon, Fassina, Volante, Nesi, Santi, Gatti, Cappellesso, Dalino Ciaramella, Ventura, Gambacorta, Dei Tos, Loli, Mannelli, Mantero, Berruti, Terzolo, Papotti (CR10) 2013; 37 Coste, Tissier, Pouchot, Ecosse, Rouquette, Bertagna, Libé, Viallon (CR17) 2014; 38 CR8 CR18 Libé, Borget, Ronchi, Zaggia, Kroiss, Kerkhofs, Bertherat, Volante, Quinkler, Chabre, Bala, Tabarin, Beuschlein, Vezzosi, Deutschbein, Borson-Chazot, Hermsen, Stell, Fottner, Leboulleux, Hahner, Mannelli, Berruti, Haak, Terzolo, Fassnacht, Baudin, ENSAT network (CR1) 2015; 26 Clay, Pinto, Fishbein, Else, Kiseljak-Vassiliades (CR4) 2022; 107 Giordano, Berney, de Krijger, Erickson, Fassnacht, Mete, Papathomas, Papotti, Sasano, Thompson, Volante, Gill (CR16) 2021; 110 CR11 Pennanen, Heiskanen, Sane, Remes, Mustonen, Haglund, Arola (CR9) 2015; 46 Assié, Jouinot, Fassnacht, Libé, Garinet, Jacob, Hamzaoui, Neou, Sakat, de La Villéon, Perlemoine, Ragazzon, Sibony, Tissier, Gaujoux, Dousset, Sbiera, Ronchi, Kroiss, Korpershoek, de Krijger, Waldmann, Quinkler, Haissaguerre, Tabarin, Chabre, Luconi, Mannelli, Groussin, Bertagna, Baudin, Amar, Coste, Beuschlein, Bertherat (CR3) 2019; 5 Duregon, Cappellesso, Maffeis, Zaggia, Ventura, Berruti, Terzolo, Fassina, Volante, Papotti (CR14) 2017; 62 Lau, Weiss (CR12) 2009; 40 Cantini, Di Franco, Mannelli, Scimè, Maggi, Luconi (CR21) 2020; 8 Beuschlein, Weigel, Saeger, Kroiss, Wild, Daffara, Libé, Ardito, Al Ghuzlan, Quinkler, Oßwald, Ronchi, de Krijger, Feelders, Waldmann, Willenberg, Deutschbein, Stell, Reincke, Papotti, Baudin, Tissier, Haak, Loli, Terzolo, Allolio, Müller, Fassnacht (CR22) 2015; 100 Mete, Erickson, Juhlin, de Krijger, Sasano, Volante, Papotti (CR5) 2022; 33 Armignacco, Cantini, Poli, Guasti, Nesi, Romagnoli, Mannelli, Luconi (CR20) 2019; 11 Armignacco, Cantini, Canu, Poli, Ercolino, Mannelli, Luconi (CR2) 2018; 41 Lalli, Luconi (CR6) 2018; 25 AMF Lacombe (9760_CR19) 2020; 12 E Lalli (9760_CR6) 2018; 25 Fassnacht M, Johanssen S, Quinkler M, Bucsky P, Willenberg HS, Beuschlein F, Terzolo M, Mueller HH, Hahner S, Allolio B; German Adrenocortical Carcinoma Registry Group; European Network for the Study of Adrenal Tumors (9760_CR13) 2009; 115 SK Lau (9760_CR12) 2009; 40 G Assié (9760_CR3) 2019; 5 9760_CR11 E Duregon (9760_CR14) 2017; 62 G Cantini (9760_CR7) 2020; 12 F Beuschlein (9760_CR22) 2015; 100 JJ Baechle (9760_CR15) 2021; 28 M Pennanen (9760_CR9) 2015; 46 R Libé (9760_CR1) 2015; 26 9760_CR18 MR Clay (9760_CR4) 2022; 107 9760_CR8 E Duregon (9760_CR10) 2013; 37 O Mete (9760_CR5) 2022; 33 R Armignacco (9760_CR2) 2018; 41 TJ Giordano (9760_CR16) 2021; 110 G Cantini (9760_CR21) 2020; 8 J Coste (9760_CR17) 2014; 38 R Armignacco (9760_CR20) 2019; 11 |
References_xml | – volume: 110 start-page: 50 year: 2021 end-page: 61 ident: CR16 article-title: Data set for reporting of carcinoma of the adrenal cortex: explanations and recommendations of the guidelines from the International Collaboration on Cancer Reporting publication-title: Hum Pathol doi: 10.1016/j.humpath.2020.10.001 contributor: fullname: Gill – volume: 107 start-page: 1159 year: 2022 end-page: 1169 ident: CR4 article-title: Pathological and genetic stratification for management of adrenocortical carcinoma publication-title: J Clin Endocrinol Metab doi: 10.1210/clinem/dgab866 contributor: fullname: Kiseljak-Vassiliades – ident: CR18 – volume: 11 start-page: 1931 year: 2019 ident: CR20 article-title: The adipose stem cell as a novel metabolic actor in adrenocortical carcinoma progression: evidence from an in vitro tumor microenvironment crosstalk model publication-title: Cancers (Basel) doi: 10.3390/cancers11121931 contributor: fullname: Luconi – volume: 41 start-page: 499 year: 2018 end-page: 507 ident: CR2 article-title: Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis publication-title: J Endocrinol Invest doi: 10.1007/s40618-017-0775-y contributor: fullname: Luconi – volume: 12 start-page: 3176 year: 2020 ident: CR7 article-title: Prognostic and monitoring value of circulating tumor cells in adrenocortical carcinoma: a preliminary monocentric study publication-title: Cancers (Basel) doi: 10.3390/cancers12113176 contributor: fullname: Luconi – volume: 28 start-page: 6551 year: 2021 end-page: 6561 ident: CR15 article-title: Cumulative GRAS score as a predictor of survival after resection for adrenocortical carcinoma: analysis from the U.S. adrenocortical carcinoma database publication-title: Ann Surg Oncol doi: 10.1245/s10434-020-09562-8 contributor: fullname: Kiernan – volume: 5 start-page: 1440 year: 2019 end-page: 1447 ident: CR3 article-title: Value of molecular classification for prognostic assessment of adrenocortical carcinoma publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2019.1558 contributor: fullname: Bertherat – ident: CR11 – volume: 38 start-page: 200 year: 2014 end-page: 208 ident: CR17 article-title: Rasch analysis for assessing unidimensionality and identifying measurement biases of malignancy scores in oncology. The example of the Weiss histopathological system for the diagnosis of adrenocortical cancer publication-title: Cancer Epidemiol doi: 10.1016/j.canep.2014.02.004 contributor: fullname: Viallon – volume: 40 start-page: 757 year: 2009 end-page: 768 ident: CR12 article-title: The Weiss system for evaluating adrenocortical neoplasms: 25 years later publication-title: Hum Pathol doi: 10.1016/j.humpath.2009.03.010 contributor: fullname: Weiss – volume: 12 start-page: 247 year: 2020 ident: CR19 article-title: Sterol O-acyl transferase 1 as a prognostic marker of adrenocortical carcinoma publication-title: Cancers (Basel) doi: 10.3390/cancers12010247.5 contributor: fullname: Fragoso – volume: 26 start-page: 2119 year: 2015 end-page: 2125 ident: CR1 article-title: Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study publication-title: Ann Oncol doi: 10.1093/annonc/mdv329 contributor: fullname: ENSAT network – volume: 46 start-page: 404 year: 2015 end-page: 410 ident: CR9 article-title: Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas publication-title: Hum Pathol doi: 10.1016/j.humpath.2014.11.015 contributor: fullname: Arola – volume: 8 start-page: 332 year: 2020 ident: CR21 article-title: The role of metabolic changes in shaping the fate of cancer-associated adipose stem cells publication-title: Front Cell Dev Biol doi: 10.3389/fcell.2020.00332 contributor: fullname: Luconi – volume: 37 start-page: 1433 year: 2013 end-page: 1440 ident: CR10 article-title: The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases publication-title: Am J Surg Pathol doi: 10.1097/PAS.0b013e31828d387b contributor: fullname: Papotti – volume: 100 start-page: 841 year: 2015 end-page: 849 ident: CR22 article-title: Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2014-3182 contributor: fullname: Fassnacht – volume: 33 start-page: 155 year: 2022 end-page: 196 ident: CR5 article-title: Overview of the 2022 WHO classification of adrenal cortical tumors publication-title: Endocr Pathol doi: 10.1007/s12022-022-09710-8 contributor: fullname: Papotti – ident: CR8 – volume: 25 start-page: R31 year: 2018 end-page: R48 ident: CR6 article-title: The next step: mechanisms driving adrenocortical carcinoma metastasis publication-title: Endocr Relat Cancer doi: 10.1530/ERC-17-0440 contributor: fullname: Luconi – volume: 115 start-page: 243 year: 2009 end-page: 250 ident: CR13 article-title: Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification publication-title: Cancer doi: 10.1002/cncr.24030 – volume: 62 start-page: 1 year: 2017 end-page: 7 ident: CR14 article-title: Validation of the prognostic role of the "Helsinki Score" in 225 cases of adrenocortical carcinoma publication-title: Hum Pathol doi: 10.1016/j.humpath.2016.09.035 contributor: fullname: Papotti – volume: 107 start-page: 1159 year: 2022 ident: 9760_CR4 publication-title: J Clin Endocrinol Metab doi: 10.1210/clinem/dgab866 contributor: fullname: MR Clay – volume: 110 start-page: 50 year: 2021 ident: 9760_CR16 publication-title: Hum Pathol doi: 10.1016/j.humpath.2020.10.001 contributor: fullname: TJ Giordano – volume: 33 start-page: 155 year: 2022 ident: 9760_CR5 publication-title: Endocr Pathol doi: 10.1007/s12022-022-09710-8 contributor: fullname: O Mete – ident: 9760_CR11 doi: 10.1007/0-387-22440-8_13 – volume: 12 start-page: 3176 year: 2020 ident: 9760_CR7 publication-title: Cancers (Basel) doi: 10.3390/cancers12113176 contributor: fullname: G Cantini – volume: 11 start-page: 1931 year: 2019 ident: 9760_CR20 publication-title: Cancers (Basel) doi: 10.3390/cancers11121931 contributor: fullname: R Armignacco – ident: 9760_CR8 – volume: 62 start-page: 1 year: 2017 ident: 9760_CR14 publication-title: Hum Pathol doi: 10.1016/j.humpath.2016.09.035 contributor: fullname: E Duregon – volume: 40 start-page: 757 year: 2009 ident: 9760_CR12 publication-title: Hum Pathol doi: 10.1016/j.humpath.2009.03.010 contributor: fullname: SK Lau – volume: 41 start-page: 499 year: 2018 ident: 9760_CR2 publication-title: J Endocrinol Invest doi: 10.1007/s40618-017-0775-y contributor: fullname: R Armignacco – volume: 115 start-page: 243 year: 2009 ident: 9760_CR13 publication-title: Cancer doi: 10.1002/cncr.24030 contributor: fullname: Fassnacht M, Johanssen S, Quinkler M, Bucsky P, Willenberg HS, Beuschlein F, Terzolo M, Mueller HH, Hahner S, Allolio B; German Adrenocortical Carcinoma Registry Group; European Network for the Study of Adrenal Tumors – volume: 26 start-page: 2119 year: 2015 ident: 9760_CR1 publication-title: Ann Oncol doi: 10.1093/annonc/mdv329 contributor: fullname: R Libé – volume: 5 start-page: 1440 year: 2019 ident: 9760_CR3 publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2019.1558 contributor: fullname: G Assié – volume: 37 start-page: 1433 year: 2013 ident: 9760_CR10 publication-title: Am J Surg Pathol doi: 10.1097/PAS.0b013e31828d387b contributor: fullname: E Duregon – volume: 28 start-page: 6551 year: 2021 ident: 9760_CR15 publication-title: Ann Surg Oncol doi: 10.1245/s10434-020-09562-8 contributor: fullname: JJ Baechle – volume: 12 start-page: 247 year: 2020 ident: 9760_CR19 publication-title: Cancers (Basel) doi: 10.3390/cancers12010247.5 contributor: fullname: AMF Lacombe – volume: 100 start-page: 841 year: 2015 ident: 9760_CR22 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2014-3182 contributor: fullname: F Beuschlein – ident: 9760_CR18 doi: 10.1210/endocr/bqac102 – volume: 8 start-page: 332 year: 2020 ident: 9760_CR21 publication-title: Front Cell Dev Biol doi: 10.3389/fcell.2020.00332 contributor: fullname: G Cantini – volume: 25 start-page: R31 year: 2018 ident: 9760_CR6 publication-title: Endocr Relat Cancer doi: 10.1530/ERC-17-0440 contributor: fullname: E Lalli – volume: 46 start-page: 404 year: 2015 ident: 9760_CR9 publication-title: Hum Pathol doi: 10.1016/j.humpath.2014.11.015 contributor: fullname: M Pennanen – volume: 38 start-page: 200 year: 2014 ident: 9760_CR17 publication-title: Cancer Epidemiol doi: 10.1016/j.canep.2014.02.004 contributor: fullname: J Coste |
SSID | ssj0013002 |
Score | 2.3876734 |
Snippet | Adrenal cortical carcinoma (ACC) is an uncommon neoplasm with variable prognosis. Several histologic criteria have been identified as predictors of malignancy... |
SourceID | pubmedcentral proquest crossref pubmed springer |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 224 |
SubjectTerms | Carcinoma Endocrinology Malignancy Medical prognosis Medicine Medicine & Public Health Necrosis Neuroendocrine tumors Oncology Pathology Principal components analysis Regression analysis Survival Tumors |
Title | Prognostic Value of Microscopic Tumor Necrosis in Adrenal Cortical Carcinoma |
URI | https://link.springer.com/article/10.1007/s12022-023-09760-6 https://www.ncbi.nlm.nih.gov/pubmed/36952130 https://www.proquest.com/docview/2825589135 https://search.proquest.com/docview/2790050113 https://pubmed.ncbi.nlm.nih.gov/PMC10264263 |
Volume | 34 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT8IwEL8oJMYXvz-maGrim86Udeu2R4IQYoCYiMa3pWUlEmUzwP5_78aAIPqgL3tom669u_Z-7X0U4BohaxALqW1XhRw_Hi4pNxS2cTRXXoiI15BFt_Xkd1-D-walyRGLq4vk_W5ukcw36mWsm0OO56hibI4qFM88m1BG3eOhcJdrjYdWe2k84IWroSttUrdFrMzPvazqozWQue4r-c1gmuuh5u6_ZrAHOwXsZLWZnOzDhkkOYKtTGNYPof04TsnlDqvZi_rIDEsHrEPOehS2goW9bJSOWddQyXDChgmrUQw49llPx_l9OKvTs0RJOlJH8Nxs9Ootu3howe67vje1RWDwZDJQptpHhKdCI_hAB14c-lzHsqpMjDBqEBsTmDzBjnQ1bgxkUpTSDxHEHUMpSRNzCkxXRezzvqNcPNjxPk5U0ePGmmtZNaF2LLiZkzv6nOXTiJaZk4lAERIoygkUSQsqc45ExdqaRBRtS28hCs-Cq0U1rgoydajEpBm2wWFxD_cuYcHJjIGL3wkZotwIbkGwwtpFA8q4vVqTDN_yzNuIxiRluLfgds7i5bh-n8bZ35qfw7aTSwnd9VSgNB1n5gI2J3F2WYj6F-879VI |
link.rule.ids | 230,315,782,786,887,27933,27934,41073,42142,48344,48347,49649,49652,52153 |
linkProvider | Springer Nature |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDLaAScCF96M8g8QNKmVNm7bHaTA2sU1IDMStStZMTGIt2uj_x-7aTeNxgEsPSZQmthN_iR8BuETIGsRCattVIcePh0vKDYVtHM2VFyLiNWTRbT763Zfg5pbS5LhlLEzu7V6aJPOdeh7s5pDnOeoYm6MOxUPPMlRc7A1luVJr9e4ac-sBL3wNXWmTvi2CZX7uZVEhfUOZ350lv1hMc0XU2PzfFLZgowCerDaVlG1YMskOrHYK0_outB_GKTndYTV7Vm-ZYemAdchdjwJXsLCXjdIx6xoqGU7YMGE1igLHPuvpOL8RZ3V6mChJR2oPnhq3vXrTLp5asPuu733YIjB4NhkoU-0jxlOhEXygAy8Ofa5jWVUmRiA1iI0JTJ5iR7oatwYyKkrphwjj9mElSRNzCExXRezzvqNcPNrxPk5U0fPGmmtZNaF2LLgq6R29TzNqRPPcyUSgCAkU5QSKpAUnJUuiYnVNIoq3pdcQhWfBxawa1wUZO1Ri0gzb4LC4h7uXsOBgysHZ74QMEbUIbkGwwNtZA8q5vViTDF_z3NuIxyTluLfgumTxfFy_T-Pob83PYa3Z67Sjdqt7fwzrTi4xdPNzAisf48ycwvIkzs4Kuf8Esa35Qg |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3JTsMwEB2xSIgL-xIoYCRuEOHGiZMcqy4qUCokFnGL7MYRlWiC2ub_mUnTVmU5IC452JbjbTxvPBvABULWIBZS264KOX48JCk3FLZxNFdeiIjXkEa3_eh3X4NGk8LkzLz4C2v3qUpy4tNAUZrS8fVHnFzPHd8cskJHfmNz5KcoAC3DqouSDJ701Vrztt2ZaxJ4aXfoSpt4b-k483Mvi8zpG-L8bjj5RXtaMKXW5v-nswUbJSBltckJ2oYlk-7A2n2pct-FzsMwI2M8rGYv6j03LEvYPZnxkUMLFj7lg2zIuoZK-iPWT1mNvMOxz3o2LF7KWZ0SFqXZQO3Bc6v5VG_bZQoGu-f63tgWgUGZJVGm2kPsp0IjeKIDLw59rmNZVSZGgJXExgSmCL0jXY1XBikbpfRDhHf7sJJmqTkEpqsi9nnPUS6KfLyHE1WU9lhzLasm1I4Fl9O1jz4mkTaieUxlWqAIFygqFiiSFlSm2xOVVDeKyA-XsiQKz4LzWTXSCylBVGqyHNvgsLiHt5qw4GCym7PfCRkimhHcgmBhn2cNKBb3Yk3afyticiNOkxT73oKr6XbPx_X7NI7-1vwM1h4arahz0707hnWnODD0IFSBlfEwNyewPIrz05IEPgGF3AIU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prognostic+Value+of+Microscopic+Tumor+Necrosis+in+Adrenal+Cortical+Carcinoma&rft.jtitle=Endocrine+pathology&rft.au=Luconi%2C+Michaela&rft.au=Cantini%2C+Giulia&rft.au=van+Leeuwaarde%2C+Rachel+S.&rft.au=Roebaar%2C+Rogina&rft.date=2023-06-01&rft.pub=Springer+US&rft.issn=1046-3976&rft.eissn=1559-0097&rft.volume=34&rft.issue=2&rft.spage=224&rft.epage=233&rft_id=info:doi/10.1007%2Fs12022-023-09760-6&rft.externalDocID=10_1007_s12022_023_09760_6 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1046-3976&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1046-3976&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1046-3976&client=summon |